Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice
- 1 October 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (10), 2106-2113
- https://doi.org/10.1161/01.atv.0000181743.28028.57
Abstract
Objective— Angiotensin (Ang) II-induced vascular damage may be partially mediated by reactive oxygen species generation and inflammation. Homozygous osteopetrotic mice (Op/Op), deficient in macrophage colony-stimulating factor (m-CSF), exhibit reduced inflammation. We therefore investigated Ang II effects on vascular structure, function, and oxidant stress generation in this model. Methods and Results— Adult Op/Op, heterozygous (Op/+), and wild type (+/+) mice underwent 14-day Ang II (1000 ng/kg per minute) or saline infusion. Blood pressure (BP) was assessed by radiotelemetry, mesenteric resistance artery vascular reactivity was studied on a pressurized myograph, and vascular superoxide and NAD(P)H oxidase activity by lucigenin chemiluminescence. Ang II increased BP in Op/+ and +/+ mice but not in Op/Op. Ang II-treated Op/+ and +/+ mice showed reduced acetylcholine-mediated relaxation (maximal relaxation, respectively, 64% and 67% versus 84% and 93% in respective controls; PPConclusions— m-CSF–deficient mice (Op/Op) developed less endothelial dysfunction, vascular remodeling, and oxidative stress induced by Ang II than +/+ littermates, suggesting a critical role of m-CSF and proinflammatory mediators in Ang II-induced vascular injury. Ang II-induced vascular damage and remodeling, which is partially mediated by ROS generation and inflammation, was investigated in a model of reduced inflammation (m-CSF–deficient mice). We demonstrated that vascular proinflammatory mediators play a crucial role in Ang II-induced endothelial dysfunction and vascular remodeling.Keywords
This publication has 34 references indexed in Scilit:
- Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial DysfunctionCirculation, 2004
- Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruliAmerican Journal of Physiology-Renal Physiology, 2004
- NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial HypertrophyArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Inflammation and Vascular Hypertrophy Induced by Angiotensin IIArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Cytochromeb558–Dependent NAD(P)H Oxidase–Phox Units in Smooth Muscle and Macrophages of Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.JCI Insight, 1998
- The p47phox mouse knock-out model of chronic granulomatous disease.The Journal of Experimental Medicine, 1995
- Epinephrine and the genesis of hypertension.Hypertension, 1992
- Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.Hypertension, 1991
- Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats.Hypertension, 1988